Biotech stocks jump on AbbVie deal to buy cancer drugmaker ImmunoGen for $10 billion
November 30, 2023 Comments Off
Other biotech companies developing ADCs, which are among the hottest areas in the pharmaceutical industry, jumped on the news of AbbVie’s buyout of ImmunoGen.
Biotech stocks jump on AbbVie deal to buy cancer drugmaker ImmunoGen for $10 billion
Other biotech companies developing ADCs, which are among the hottest areas in the pharmaceutical industry, jumped on the news of AbbVie’s buyout of ImmunoGen.
Archives
Categories
Archives
Recent Posts
Meta
Categories
Calender